Clinical Profiles of Chronic Medication Use Among Patients With Non-Valvular Atrial Fibrillation

被引：0
|
作者：
Kocis, Paul T.
Liu, Guodong
Trocio, Jeffrey N.
Makenbaeva, Dinara
Baab, Kendall M.
Trainer, JoAnn B.
Abdulsattar, Younos
Molina, Marta I.
Leslie, Douglas L.
机构：
来源：
CIRCULATION | 2014年 / 130卷
关键词：
Atrial fibrillation; Anticoagulants; Anticoagulation; Risk factors; Drugs;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
11042
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Use of Chronic Medications Among Patients with Non-Valvular Atrial Fibrillation
    Kocis P.T.
    Liu G.
    Makenbaeva D.
    Trocio J.
    Velott D.
    Trainer J.A.B.
    Abdulsattar Y.
    Molina M.I.
    Leslie D.L.
    Drugs - Real World Outcomes, 2016, 3 (2) : 165 - 173
  • [2] Angiographic Profiles in Persistent Non-Valvular Atrial Fibrillation Patients
    Batta, A.
    Sharma, Y. P.
    Makkar, K.
    Panda, P.
    Barwad, P.
    EUROPEAN HEART JOURNAL, 2022, 43
  • [3] Adherence to medication and characteristics of Japanese patients with non-valvular atrial fibrillation
    Suzuki, Tsuyoshi
    Shiga, Tsuyoshi
    Omori, Hisako
    Tatsumi, Fujio
    Nishimura, Katsuji
    Hagiwara, Nobuhisa
    JOURNAL OF CARDIOLOGY, 2017, 70 (3-4) : 238 - 243
  • [4] Medication persistence and discontinuation of rivaroxaban and dabigatran etexilate among patients with non-valvular atrial fibrillation
    Nelson, Winnie W.
    Song, Xue
    Thomson, Erin
    Smith, David M.
    Coleman, Craig I.
    Damaraju, C. V.
    Schein, Jeffrey R.
    CURRENT MEDICAL RESEARCH AND OPINION, 2015, 31 (10) : 1831 - 1840
  • [5] Medication persistence and discontinuation of rivaroxaban versus warfarin among patients with non-valvular atrial fibrillation
    Nelson, Winnie W.
    Song, Xue
    Coleman, Craig I.
    Thomson, Erin
    Smith, David M.
    Damaraju, C. V.
    Schein, Jeffrey R.
    CURRENT MEDICAL RESEARCH AND OPINION, 2014, 30 (12) : 2461 - 2469
  • [6] Patterns of use of antithrombotic therapy and quality of anticoagulation among patients with non-valvular atrial fibrillation in clinical practice
    Boulanger, L
    Kim, J
    Friedman, M
    Hauch, O
    Foster, T
    Menzin, J
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2006, 60 (03) : 258 - 264
  • [7] Prescription pattern among oncologic patients with non-valvular atrial fibrillation
    Toma, Matteo
    Giovinazzo, Stefano
    Tini, Giacomo
    Sarocchi, Matteo
    Sirello, Davide
    Miceli, Roberta
    Arboscello, Eleonora
    Porto, Italo
    Spallarossa, Paolo
    Ameri, Pietro
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2019, 21 (0J) : J28 - J29
  • [8] Clinical impact of switching or continuation of apixaban or rivaroxaban among patients with non-valvular atrial fibrillation
    Deitelzweig, S.
    Kang, A.
    Jiang, J.
    Gao, C.
    Luo, X.
    Atreja, N.
    Han, S.
    Cheng, D.
    Lip, G.
    EUROPEAN HEART JOURNAL, 2023, 44
  • [9] Clinical Impact of Switching or Continuation of Apixaban or Rivaroxaban among Patients with Non-Valvular Atrial Fibrillation
    Deitelzweig, Steven
    Kang, Amiee
    Jiang, Jenny
    Gao, Chuan
    Luo, Xuemei
    Atreja, Nipun
    Han, Stella
    Cheng, Dong
    Loganathan, Saarusri R.
    Lip, Gregory Y. H.
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (04)
  • [10] Risk profiles and pattern of antithrombotic use in patients with non-valvular atrial fibrillation in Thailand: a multicenter study
    Rungroj Krittayaphong
    Arjbordin Winijkul
    Komsing Methavigul
    Wattana Wongtheptien
    Chaiyasith Wongvipaporn
    Treechada Wisaratapong
    Rapeephon Kunjara-Na-Ayudhya
    Smonporn Boonyaratvej
    Chulalak Komoltri
    Pontawee Kaewcomdee
    Ahthit Yindeengam
    Piyamitr Sritara
    BMC Cardiovascular Disorders, 18
12345